Gulf International Bank (UK) Ltd / ABT
Gulf International Bank (UK) Ltd’s Abbott Laboratories Position
Does Gulf International Bank (UK) Ltd own Abbott Laboratories (ABT)? Yes — 134.3K shares worth $14M (+0.31% of its 13F portfolio) as of Q1 2026, up from 88.1K shares the prior filed quarter.
Position Value
$14M
Q1 2026
Shares
134.3K
% of Portfolio
+0.31%
Quarters Held
29
currently held
Position History ABT
Reported value by quarter
| Quarter | Shares | Value | % of Portfolio |
|---|---|---|---|
| Q1 2026 | 134.3K | $14M | +0.31% |
| Q4 2025 | 88.1K | $11M | +0.36% |
| Q3 2025 | 88.1K | $12M | +0.39% |
| Q2 2025 | 88.8K | $12M | +0.43% |
| Q1 2025 | 99.8K | $13M | +0.46% |
| Q4 2024 | 134.4K | $15M | +0.38% |
| Q3 2024 | 135.9K | $15M | +0.40% |
| Q2 2024 | 141.6K | $15M | +0.37% |
| Q1 2024 | 154.9K | $18M | +0.44% |
| Q4 2023 | 149.0K | $16M | +0.46% |
| Q3 2023 | 165.1K | $16M | +0.45% |
| Q2 2023 | 183.3K | $20M | +0.50% |
| Q1 2023 | 237.7K | $24M | +0.50% |
| Q4 2022 | 301.7K | $33M | +0.58% |
| Q3 2022 | 303.2K | $29M | +0.55% |
| Q2 2022 | 302.8K | $33M | +0.58% |
| Q1 2022 | 302.1K | $36M | +0.53% |
| Q4 2021 | 301.9K | $42M | +0.60% |
| Q3 2021 | 361.0K | $43M | +0.55% |
| Q2 2021 | 355.9K | $41M | +0.52% |
| Q1 2021 | 357.1K | $43M | +0.59% |
| Q4 2020 | 398.3K | $44M | +0.57% |
| Q3 2020 | 426.2K | $46M | +0.65% |
| Q2 2020 | 427.2K | $39M | +0.60% |
| Q1 2020 | 423.5K | $33M | +0.63% |
| Q4 2019 | 424.1K | $37M | +0.56% |
| Q3 2019 | 424.8K | $36M | +0.59% |
| Q2 2019 | 424.1K | $36M | +0.60% |
| Q1 2019 | 412.9K | $33M | +0.57% |
Common-stock position only; options are excluded. Quarters where the fund filed no 13F or reported no position are absent. See Gulf International Bank (UK) Ltd’s full portfolio or all institutional holders of ABT.